Drug Biz Worried Over User Fees' Fate Under Sequestration
John Castellani, president and CEO of PhRMA, explained what the industry thinks will happen if the sequestration goes into effect, slicing more than 8 percent from the FDA's budget.
“The fear is twofold,” Castellani said.
First, the FDA's appropriated funds will be...
To view the full article, register now.